Profile: Permaxim discovers, develops & markets rediscreen point-of-care, rapid diagnostic tests for detection of pregnancy, strep A, drugs of abuse, occult blood, H. pylori and urinalysis detected conditions. Our fecal occult blood tests are a rapid, convenient and qualitative method for the early detection of asymptomatic fecal occult bleeding.